AMGN vs COMP · P/E 24, rev $36.75B vs rev $5.63B
Amgen Inc (AMGN) versus Compass Inc (COMP) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Compass Inc (COMP) is a real estate services company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. COMP currently screens at market cap $3.35B.
Not investment advice. Open the AMGN and COMP stock pages for the full models.
Not investment advice.